
Research & Development
Research & Development
Our Innovations
At Servier Pharmaceuticals, we are committed to making the world a better place for the patients we serve. Our research focuses on five key therapeutic areas: Oncology, Cardiology, Metabolism, Immune-Inflammatory and Neuroscience. Our extensive know-how and expertise position us to best address the unmet needs of patients. Servier draws on the excellence of its Research & Development (R&D) employees worldwide to develop effective treatment solutions.
Our Therapeutic Areas
Servier Pharmaceuticals is committed to reinvesting in research to help discover new treatments that improve our patients' lives. To fuel the next generation of discovery, we are reinvesting more of our total revenue back into our own R&D and innovative partnerships than into life-cycle management. We are not interested in investing in incremental projects but are looking to invest in the big advances that truly move the needle for our patients.
Therapies in development are being investigated for patient use and are not approved by the FDA.
More from Servier
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States. Globally, our pipeline includes a robust portfolio of treatments for various therapeutic areas.
Learn MoreClinical Trials
We strive to have consistent and concise transparency throughout all our clinical trials and research and development for the benefit of our patients.
Learn MoreMedicines
Servier Pharmaceuticals' medicines change the lives of the patients we serve. Currently, within the United States, oncology treatment and care are our immediate focus.
Learn More